Puma Biotechnology (PBYI) Current Leases (2019 - 2026)
Puma Biotechnology's (PBYI) quarterly Current Leases came in at $125000.0 in Q1 2026, down 97.82% YoY from $5.7 million in Q1 2025, and down 90.49% on a QoQ basis from $1.3 million in Q4 2025.
Puma Biotechnology (PBYI) Current Leases (2019 - 2026) Analysis & Trends
Puma Biotechnology (PBYI) has 8 years of Current Leases data on file, last reported at $125000.0 in Q1 2026.
- Quarterly Current Leases fell 97.82% year-over-year to $125000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125000.0 (down 97.82% YoY) and the FY2025 annual result came in at $1.3 million, down 76.28% from the prior year.
- Current Leases declined to $125000.0 in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $5.7 million in Q1 2025 to a low of $125000.0 in Q1 2026.
- A 5-year average of $4.1 million and a median of $4.4 million in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases grew 16.2% — and 2026, when it sank 97.82%.
- Tracing PBYI's Current Leases over 5 years: stood at $4.1 million in 2022, then advanced by 15.94% to $4.8 million in 2023, then grew by 15.42% to $5.5 million in 2024, then tumbled by 76.28% to $1.3 million in 2025, then tumbled by 90.49% to $125000.0 in 2026.
- The last three Current Leases figures came in at $125000.0 (Q1 2026), $1.3 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Puma Biotechnology | 451.24 Mn | 357.33 Mn | 44.03 Mn | 450,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 450,000.00 |
| Mar 31, 2026 | 125,000.00 |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 2.47 Mn |
| Jun 30, 2025 | 4.36 Mn |
| Mar 31, 2025 | 5.74 Mn |
| Dec 31, 2024 | 5.54 Mn |
| Sep 30, 2024 | 5.35 Mn |
| Jun 30, 2024 | 5.16 Mn |
| Mar 31, 2024 | 4.98 Mn |
| Dec 31, 2023 | 4.80 Mn |
| Sep 30, 2023 | 4.63 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Mar 31, 2023 | 4.30 Mn |
| Dec 31, 2022 | 4.14 Mn |
| Sep 30, 2022 | 3.99 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Mar 31, 2022 | 3.70 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Sep 30, 2021 | 3.45 Mn |